Skip to content

0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Critically Ill Children

Randomized, Controlled, Double Blinded, Clinical Trial: 0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Critically Ill Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01301274
Acronym
NaCrICh
Enrollment
66
Registered
2011-02-23
Start date
2011-02-28
Completion date
2011-11-30
Last updated
2012-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyponatremia

Keywords

hyponatremia, maintenance solutions, pediatrics

Brief summary

The primary objective of this study is to compare the mean serum sodium after 48 hours of therapy with either 0.45% NaCl/dextrose 5% or 0.9% NaCl/dextrose 5%, in critically ill children requiring IV maintenance fluid administration.

Detailed description

In patients without possibilities of oral intake, maintenance fluids provide electrolytes and water. Since the original descriptions by Holliday and Segar, the recommended standard maintenance solutions are based on physiological needs, containing 30-50 mEq/L of sodium. However hyponatremia has become increasingly recognized in hospitalized children suggesting that Holliday and Segar's recommendations are frequently inappropriately applied. It has been described augmented intersticial lung water in patients receiving hypotonic maintenance solutions. Also, hyponatremia has been demonstrated in post-surgery critically ill children receiving hypotonic maintenance solutions. More over, non-physiologic antidiuretic hormone (ADH) secretion has been described in the great majority of hospitalized children due to nausea, stress, pain, and/or surgical interventions. It has been suggested that isotonic 0.9% NaCl/dextrose 5% should be the standard maintenance intravenous (IV) solution, to avoid the development of hyponatremia. There are not studies in critically ill children evaluating the effect of isotonic solutions on sodium levels.

Interventions

0.45% NaCl/5% dextrose IV maintenance fluids

0.9% NaCl/5% dextrose IV maintenance fluids

Sponsors

Hospital General de Niños Pedro de Elizalde
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Months to 18 Years
Healthy volunteers
No

Inclusion criteria

* Age 1 month to 18 years * ICU stay \>24 hours * Normal seric sodium (135 - 145 mEq/L). * Requirement of IV maintenance solutions \>80% total fluids intake

Exclusion criteria

* Patients with diagnoses of renal failure (serum creatinine \>1 g/dl in \<3 years old children, \>1,5 in \>3 years), hepatic failure with ascitis and portal hypertension, adrenal failure, nephrotic - nephritic syndrome, Kawasaki disease, sickle cell anemia, Syndrome of inappropriate antidiuretic hormone secretion, diabetes insipidus,metabolic disease. * Diuretics use in the first 48 hours thereafter indicated IV solutions. * Plasma glucose is \>200 mg%. * Any patients requiring IV fluids therapy different that maintenance (total parenteral nutrition, hyperhydration).

Design outcomes

Primary

MeasureTime frameDescription
Serum Sodium Levels in Both Groupsfirst 48 hoursMean serum sodium level of each group will be compared at baseline and in the first 48 hours of IV fluid infusion

Secondary

MeasureTime frameDescription
Mortality at 28 Days28 days after admissionMortality in both groups will be compared 28 days after admission
Mechanical Ventilation Free Days at 28 Day of Admissionfirst 28 day after starting mechanical ventilationmechanical ventilation free days at the first 28 day of starting mechanical ventilation, if the patient died the corresponding value is zero.
ICU Length of Stay180 daysICU length of stay (in days)

Countries

Argentina

Participant flow

Recruitment details

Intensive Care Unit without cardiovascular patients, since 01/02/2011 until 01/11/2011

Pre-assignment details

251 admitted patients to ICU, 97 eligible patients, 9 patients did not give consent, 22 were not randomized by treatment physician

Participants by arm

ArmCount
Hypotonic
Subjects in this arm will receive 0.45% NaCl/5% dextrose intravenous maintenance fluids.
34
Isotonic
Subjects in this arm will receive 0.9% NaCl/5% dextrose intravenous maintenance fluids.
32
Total66

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyPhysician Decision21

Baseline characteristics

CharacteristicIsotonicHypotonicTotal
Age, Categorical
<=18 years
32 Participants34 Participants66 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age Continuous1.2 years
STANDARD_DEVIATION 3.2
3 years
STANDARD_DEVIATION 4.7
2.2 years
STANDARD_DEVIATION 4.1
Region of Enrollment
Argentina
32 participants34 participants66 participants
Sex: Female, Male
Female
12 Participants14 Participants26 Participants
Sex: Female, Male
Male
20 Participants20 Participants40 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
5 / 344 / 32
serious
Total, serious adverse events
4 / 340 / 32

Outcome results

Primary

Serum Sodium Levels in Both Groups

Mean serum sodium level of each group will be compared at baseline and in the first 48 hours of IV fluid infusion

Time frame: first 48 hours

ArmMeasureValue (MEAN)Dispersion
Hypotonic ArmSerum Sodium Levels in Both Groups137.8 mEq/LStandard Deviation 4.3
Isotonic ArmSerum Sodium Levels in Both Groups140.0 mEq/LStandard Deviation 4.1
p-value: 0.04t-test, 2 sided
Secondary

ICU Length of Stay

ICU length of stay (in days)

Time frame: 180 days

ArmMeasureValue (MEAN)Dispersion
Hypotonic ArmICU Length of Stay8.5 daysStandard Deviation 5.5
Isotonic ArmICU Length of Stay11.9 daysStandard Deviation 11.5
p-value: 0.129t-test, 2 sided
Secondary

Mechanical Ventilation Free Days at 28 Day of Admission

mechanical ventilation free days at the first 28 day of starting mechanical ventilation, if the patient died the corresponding value is zero.

Time frame: first 28 day after starting mechanical ventilation

ArmMeasureValue (MEAN)Dispersion
Hypotonic ArmMechanical Ventilation Free Days at 28 Day of Admission19.9 daysStandard Deviation 7.9
Isotonic ArmMechanical Ventilation Free Days at 28 Day of Admission21.5 daysStandard Deviation 6.6
p-value: 0.396t-test, 2 sided
Secondary

Mortality at 28 Days

Mortality in both groups will be compared 28 days after admission

Time frame: 28 days after admission

Population: The analysis was per intention to treat

ArmMeasureValue (NUMBER)
Hypotonic ArmMortality at 28 Days3 participants
Isotonic ArmMortality at 28 Days0 participants
p-value: 0.081Chi-squared

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026